Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn Pugh

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Mental Health Today (Brighton, England)|November 13, 2008
Getting ready for changeKathryn Pugh
Mental Health Today (Brighton, England)|March 28, 2007
How do we help young people negotiate the difficult path to adulthood?Kathryn Pugh
Mental Health Today (Brighton, England)|May 14, 2011
Taking the leapKathryn Pugh
Child and Adolescent Mental Health|July 19, 2020
Editorial: CAMHS goes mainstreamPeter Fonagy, Kathryn Pugh
Molecular Cancer Therapeutics|July 6, 2022
Efficacy, Tolerability, and Pharmacokinetic Studies of Antibody-Drug Conjugates Containing a Low-Potency Pyrrolobenzodiazepine DimerStephen J Gregson, Kathryn Pugh, Neki Patel, et al.
Molecular Cancer Therapeutics|March 3, 2021
Resistance to Pyrrolobenzodiazepine Dimers Is Associated with SLFN11 Downregulation and Can Be Reversed through Inhibition of ATRShenlan Mao, Raghothama Chaerkady, Wen Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2025
Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing CancersJason J Zoeller, Ravinder Tammali, Roger B Dodd, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Mental Health Today (Brighton, England)|November 13, 2008
Getting ready for changeKathryn Pugh
Mental Health Today (Brighton, England)|March 28, 2007
How do we help young people negotiate the difficult path to adulthood?Kathryn Pugh
Mental Health Today (Brighton, England)|May 14, 2011
Taking the leapKathryn Pugh
Child and Adolescent Mental Health|July 19, 2020
Editorial: CAMHS goes mainstreamPeter Fonagy, Kathryn Pugh
Molecular Cancer Therapeutics|July 6, 2022
Efficacy, Tolerability, and Pharmacokinetic Studies of Antibody-Drug Conjugates Containing a Low-Potency Pyrrolobenzodiazepine DimerStephen J Gregson, Kathryn Pugh, Neki Patel, et al.
Molecular Cancer Therapeutics|March 3, 2021
Resistance to Pyrrolobenzodiazepine Dimers Is Associated with SLFN11 Downregulation and Can Be Reversed through Inhibition of ATRShenlan Mao, Raghothama Chaerkady, Wen Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2025
Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing CancersJason J Zoeller, Ravinder Tammali, Roger B Dodd, et al.
Pageof 1